Portuguese study reveals how benralizumab works in real life for severe asthma
NCT ID NCT07159295
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked back at medical records of 74 adults in Portugal with severe eosinophilic asthma who were treated with benralizumab. Researchers wanted to describe patient characteristics, treatment patterns, and outcomes in real-world settings. The study did not test a new treatment but gathered information to understand how benralizumab is used outside of clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- benralizumab
- What this could lead to
- If successful, this study could help doctors understand how well benralizumab works in everyday practice for severe asthma patients in Portugal.
- What could go wrong
- This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to other countries or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHTMAD
Vila Real, 5000-508, Portugal
-
CHUA
Faro, 8000-368, Portugal
-
CHUA
Portimão, 8500-338, Portugal
-
CHUC - Imunoalergologia
Coimbra, 3000 -076, Portugal
-
CHUC - Pneumologia
Coimbra, 3000 -076, Portugal
-
CHUSJ - Imuno
Porto, 4200 - 319, Portugal
-
CHUSJ - Pneumo
Porto, 4200 - 319, Portugal
-
CHVNGE
Vila Nova de Gaia, 4430 - 999, Portugal
-
Chln - Hsm
Lisbon, 1649-035, Portugal
-
Chuln - Hsm
Lisbon, 1649-035, Portugal
-
Chusj - Cri
Porto, 4200-319, Portugal
-
HSMM
Barcelos, 4750-275, Portugal
-
Hospital Distrital de Santarém
Santarém, 2005-177, Portugal
-
Hospital Leiria
Leiria, 2410-197, Portugal
-
Hospital Pedro Hispano
Matosinhos Municipality, 4464-513, Portugal
-
Hospital Prof. Dr. Fernando Fonseca
Amadora, 2720-276, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A two-step strategy: biologic drug may pave the way for immunotherapy in severe olive pollen asthma
- Could a biologic drug free severe asthma patients from High-Dose steroids?
- Beyond breathing: could an asthma drug lift emotional burdens for patients and partners?
- Scientists probe why tezepelumab doesn't stop all asthma attacks
- Smart inhalers track Fasenra's asthma control over full dosing cycle
- Exercise boosts asthma control in severe cases, trial investigates